Other Consolidated Financial Statement Detail (Tables)

12 Months Ended

Dec. 31, 2011

Other Consolidated Financial Statement Detail / Collaborations [Abstract]

Supplementary Cash Flow Information

	For the Years Ended December 31,
(In millions)	2011		2010		2009
Cash paid during the year for:
Interest	$	66.7	$	68.1	$	68.1
Income taxes	$	332.7	$	394.7	$	745.4

Other income (expense), net

	For the Years Ended December 31,
(In millions)	2011			2010			2009
Interest income	$	19.2		$	22.3		$	48.5
Interest expense		(33.0	)		(36.1	)		(35.8	)
Impairments on investments		(11.5	)		(21.3	)		(10.6	)
Gain (loss) on sales of investments, net		17.4			16.3			22.8
Foreign exchange gains (losses), net		(6.3	)		(3.5	)		11.4
Other, net		0.7			3.3			1.0
Total other income (expense), net	$	(13.5	)	$	(19.0	)	$	37.3

Other current assets

	As of December 31,
(In millions)	2011		2010
Deferred tax assets	$	8.1	$	112.2
Derivative assets		39.5		1.3
Prepaid taxes		15.2		31.4
Receivable from collaborations		11.4		7.3
Interest receivable		6.5		4.9
Other prepaid expenses		45.5		47.9
Other		18.4		10.8
Total other current assets	$	144.6	$	215.8

Accrued Expenses and Other

	As of December 31,
(In millions)	2011		2010
Employee compensation and benefits	$	176.3	$	159.7
Revenue-related rebates		115.0		105.3
Deferred revenue		69.6		41.3
Royalties and licensing fees		47.4		45.1
Collaboration expenses		44.2		31.6
Clinical development expenses		40.8		24.4
Construction in progress accrual		22.8		16.4
Interest payable		21.6		21.6
Current portion of contingent consideration		10.8		11.9
Restructuring charges		1.4		66.4
Derivative liabilities		0.5		12.2
Other		126.8		130.0
Total accrued expenses and other	$	677.2	$	665.9